Elicera Therapeutics AB (publ) (STO:ELIC)

Elicera Therapeutics AB Revenue

Elicera Therapeutics AB had revenue of -147.66K SEK in the quarter ending June 30, 2026. This brings the company's total for the last twelve months to 7.79M, up 29.45% year-over-year. In the year 2025, Elicera Therapeutics AB had annual revenue of 10.86M with 52.28% growth. That makes Elicera Therapeutics AB the 43,990th largest company in the world by revenue and 682nd in Sweden.

• Revenue (ttm): 7.79M
• Revenue Growth: +29.45%
• P/S Ratio: 22.74
• Revenue / Employee: 2.60M
• Employees: 3
• Market Cap: 178.19M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	10.86M	3.73M	52.28%
Dec 31, 2024	7.13M	-4.10M	-36.52%
Dec 31, 2023	11.23M	9.95M	777.23%
Dec 31, 2022	1.28M	1.28M	217,987.39%
Dec 31, 2021	587.00	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-
Dec 31, 2016	-	-	-
Dec 31, 2015	750.00K	-	-

Data Source: Fiscal.ai Last updated: Aug 28, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 31, 2026

Data Sources Report a data error